贾威苏安佐伦 (Jiawei Suanzaoren) ,用于治疗更年期前失眠:临床观察和实验研究
Li-Qiong Chen1, Yong-Can Zhou1, Fang Ning1
1Department of Psychiatry, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Frontiers in pharmacology
|February 13, 2025
概括
贾威苏安扎奥伦 (Jiawei Suanzaoren Tang,简称JW-SZRT) 通过改善睡眠质量和调节激素水平,有效治疗绝经前期的失眠. 这种传统中医药可能通过影响神经活性联结体受体相互作用来起作用,为管理睡眠障碍提供了一个有前途的替代方案.
科学领域:
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 绝经前失眠是一种常见的疾病,对生活质量产生重大影响.
- 传统中国医学 (TCM) 提供了治疗性益处,对于绝经前期的失眠.
- 贾威苏安佐伦 (Jiawei Suanzaoren Tang,简称JW-SZRT) 是一种特定的中医配方,在阴缺乏症和火过量类型失眠中显示出有效性.
研究的目的:
- 为了评估JW-SZRT在治疗绝经前期失眠的临床疗效与洛拉泽相比.
- 通过网络药理学和动物模型研究JW-SZRT的潜在机制.
- 探索JW-SZRT对睡眠质量,激素水平和神经递质受体表达的影响.
主要方法:
- 一项随机对照试验比较JW-SZRT与80名绝经前妇女的洛拉泽帕姆.
- 网络药理学分析以确定JW-SZRT在失眠中的目标和途径.
- 动物实验使用大鼠模式的绝经期失眠来评估睡眠,荷尔蒙水平和下丘脑神经递质受体表达.
主要成果:
- 与对照组相比,JW-SZRT显著改善了睡眠质量和激素水平 (P < 0.05).
- 网络药理学建议JW-SZRT调节神经活性连接体受体相互作用.
- 动物研究证实了JW-SZRT在改善睡眠和改变下丘脑5-HT和GABAA受体表达方面的有效性 (P <0.05).
结论:
- 贾威苏安扎奥伦开有效改善绝经前期的失眠.
- 治疗机制涉及调节雌激素,FSH,LH水平,以及5-HT和GABA受体的下丘脑表达.
- 简介:JW-SZRT为绝经前失眠提供了一个可行的治疗选择.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
429
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
683
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
